Tracer library / [177Lu]Lu-lipiodol

[177Lu]Lu-lipiodol

Also written as [177Lu]Lu-lipiodol
Radionuclide
Lu-177
Modality
—
Production route
—
Stage
Preclinical
Syntheses indexed
0
Hepatobiliary and pancreatic cancer

What it is

Compound class
Lipiodol (iodinated poppy seed oil) radiolabelled with 177Lu
Target / mechanism
—
Clinical application
Hepatocellular carcinoma PMID 40465118
Theranostic pair
—

Published syntheses

No synthesis has been parsed for this agent yet.

Clinical literature

Clinical studies in the indexed corpus, ordered by design (multicentre, prospective, retrospective, others, case reports last) and then by year. Titles and links only, as published; this is not a summary of the evidence.

  1. Intraarterial HCC therapy with I-131-Lipiodol.
    2000 · Cancer Biother Radiopharm · Clinical study

Need this precursor?We can point you to suppliers for [177Lu]Lu-lipiodol, or handle the enquiry for you.

Get in touch

Notes

Added at stage 39 (2026-09-27) from a reverse search of the PubMed corpus's own unattached articles (articles that named a real compound not yet in this reference): 4 article(s) found under this name, not yet individually researched. Target/mechanism, clinical application, indications, approval, modality, stage and production route are intentionally left empty. PMIDs: 8935963, 10740654, 18243840, 40465118. Stage set/updated at stage 39 from PMID 40465118: 'This study aimed to evaluate the partition coefficient, biodistribution, and antitumor efficacy of 177Lu-lipiodol in a preclinical xenograft model.'.